We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retinal Venous Pressure (RVP) in Normals

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01732042
First Posted: November 22, 2012
Last Update Posted: December 11, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
  Purpose
Determinate the standard values of the retinal venous pressure in a cohort of healthy subjects.

Condition
Healthy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Retinal Venous Pressure (RVP) in Normals

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Retinal venous pressure [ Time Frame: 1 hour ]
    Quantification of the retinal venous pressure as a standard value in a cohort of healthy volunteers


Enrollment: 200
Study Start Date: November 2011
Study Completion Date: December 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Detailed Description:

The retinal venous pressure (RVP) is an increasingly important dimension in the clinical assessment of retinal blood flow.

In literature only very few and also divergent data on the retinal venous pressure in healthy volunteers are described. A normal value study will provide us with an up-to-date database.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy volunteers
Criteria

Inclusion Criteria:

  • healthy

Exclusion Criteria:

  • eye diseases
  • systemic diseases
  • term medication (except contraceptives)
  • pregnancy
  • allergies to the ingredients Alcaine, Tropicamide and Phenylephrine
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01732042


Locations
Switzerland
University of Basel, Dept. of Ophthalmology
Basel, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Study Director: Josef Flammer, MD University of Basel, Dept. of Ophthalmology
  More Information

Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01732042     History of Changes
Other Study ID Numbers: USB-2011-326
First Submitted: October 24, 2012
First Posted: November 22, 2012
Last Update Posted: December 11, 2013
Last Verified: December 2013

Keywords provided by University Hospital, Basel, Switzerland:
retinal venous pressure